High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and grades.

Autor: Horvat-Menih, Ines, Li, Hao, Priest, Andrew N., Li, Shaohang, Gill, Andrew B., Mendichovszky, Iosif A., Francis, Susan T., Warren, Anne Y., O'Carrigan, Brent, Welsh, Sarah J., Jones, James O., Riddick, Antony C. P., Armitage, James N., Mitchell, Thomas J., Stewart, Grant D., Gallagher, Ferdia A.
Předmět:
Zdroj: European Radiology Experimental; 7/10/2024, Vol. 8 Issue 1, p1-11, 11p
Abstrakt: Background: Clinical imaging tools to probe aggressiveness of renal masses are lacking, and T2-weighted imaging as an integral part of magnetic resonance imaging protocol only provides qualitative information. We developed high-resolution and accelerated T2 mapping methods based on echo merging and using k-t undersampling and reduced flip angles (TEMPURA) and tested their potential to quantify differences between renal tumour subtypes and grades. Methods: Twenty-four patients with treatment-naïve renal tumours were imaged: seven renal oncocytomas (RO); one eosinophilic/oncocytic renal cell carcinoma; two chromophobe RCCs (chRCC); three papillary RCCs (pRCC); and twelve clear cell RCCs (ccRCC). Median, kurtosis, and skewness of T2 were quantified in tumours and in the normal-adjacent kidney cortex and were compared across renal tumour subtypes and between ccRCC grades. Results: High-resolution TEMPURA depicted the tumour structure at improved resolution compared to conventional T2-weighted imaging. The lowest median T2 values were present in pRCC (high-resolution, 51 ms; accelerated, 45 ms), which was significantly lower than RO (high-resolution; accelerated, p = 0.012) and ccRCC (high-resolution, p = 0.019; accelerated, p = 0.008). ROs showed the lowest kurtosis (high-resolution, 3.4; accelerated, 4.0), suggestive of low intratumoural heterogeneity. Lower T2 values were observed in higher compared to lower grade ccRCCs (grades 2, 3 and 4 on high-resolution, 209 ms, 151 ms, and 106 ms; on accelerated, 172 ms, 160 ms, and 102 ms, respectively), with accelerated TEMPURA showing statistical significance in comparison (p = 0.037). Conclusions: Both high-resolution and accelerated TEMPURA showed marked potential to quantify differences across renal tumour subtypes and between ccRCC grades. Trial registration: ClinicalTrials.gov, NCT03741426. Registered on 13 November 2018. Relevance statement: The newly developed T2 mapping methods have improved resolution, shorter acquisition times, and promising quantifiable readouts to characterise incidental renal masses. Key points: • T2-weighted sequences are used for evaluation of renal masses, offering qualitative information. • This high-resolution and accelerated T2 mapping revealed quantitative differences in renal tumours. • Shorter acquisition times for T2 mapping enhance potential for clinical application. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: